Elizabeth Faust
Director/Board Member bei BIOMEA FUSION, INC.
Vermögen: - $ am 31.03.2024
Profil
Elizabeth A.
Faust is an Independent Director at Biomea Fusion, Inc. She previously worked as an Executive Director-Regional Medical Liaisons at Amgen, Inc., Senior Director-Medical Affairs at Gloucester Pharmaceuticals, Inc., Vice President-Medical Affairs at Pharmacyclics LLC, Vice President-Medical Affairs at Kite Pharma, Inc., and Executive Vice President-Medical Affairs at Tricida, Inc. Faust holds a doctorate from the University of California, Los Angeles, an undergraduate degree from Auburn University, and a graduate degree from the University of California, Riverside.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOMEA FUSION INC
-.--% | 14.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Elizabeth Faust
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOMEA FUSION, INC. | Director/Board Member | 01.06.2022 |
Ehemalige bekannte Positionen von Elizabeth Faust
| Unternehmen | Position | Ende |
|---|---|---|
| TRICIDA, INC. | Chief Tech/Sci/R&D Officer | 01.08.2020 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | - |
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | 01.11.2015 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Chief Tech/Sci/R&D Officer | 01.05.2010 |
| AMGEN INC. | Corporate Officer/Principal | - |
Ausbildung von Elizabeth Faust
| University of California, Los Angeles | Doctorate Degree |
| Auburn University | Undergraduate Degree |
| University of California, Riverside | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| TRICIDA, INC. | Health Technology |
| BIOMEA FUSION, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
